24 December 2021: The Federal Ministers give a final decision (positive with conditions) for this trial
File:
Trial reference:
Phase I/II study to evaluate the safety and effects on Progranulin levels of PR006 in patients with Fronto-Temporal Dementia with Progranulin mutations (FTD-GRN).